Latest News

  • Klikdokter Supports BKKBN in Launching the Klikkb Application

    Thursday, August 20, 2020
    Klikdokter Supports BKKBN in Launching the Klikkb Application

    Jakarta, 20 August 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary, KlikDokter, is supporting the National Population and Family Planning Agency (BKKBN) in launching the 'klikkb' application that will directly connect the acceptors of KB with midwives and allowing acceptors to receive interactive information, or counseling. The launch of klikkb is presented by dr. Hasto Wardoyo, Sp.OG(K), Chief of the National Population and Family Planning Agency (BKKBN), Dr. Daeng M Faqih, SH., MH., Chairman of the Indonesian Doctors' Association (IDI); and Bonny Anom, Deputy CEO of KlikDokter, at the headquarters of BKKBN in Jakarta.  

  • Kalbe Educates on Autoimmune Disease Sjogren's Syndrome

    Thursday, August 6, 2020
    Kalbe Educates on Autoimmune Disease Sjogren's Syndrome

    Jakarta, 6 August 2020, PT Kalbe Farma Tbk (Kalbe) held a webinar health education for the media with the theme 'Recognizing Sjögren's Syndrome: Autoimmune Disease that is often Undiagnosed,’ with speakers: Dr. dr. Alvina Widhani SpPD, K-AI, Clinical Immunological Allergy Division of the Internal Medicine Department of FKUI/RSCM/RSUI and Board of Trustees of the Indonesian Sjögren's Syndrome Foundation; and Ir. Yennel S. Suzia, MSc., Sjögren's Syndrome Survivor. 

  • Kalbe Launches Probiotic Support for the First 1000 Days of Life

    Thursday, July 30, 2020
    Kalbe Launches Probiotic Support for the First 1000 Days of Life

    Jakarta, 30 July 2020, PT Kalbe Farma Tbk (Kalbe) today launches a probiotic product to optimize the digestive health of Indonesian infants and toddlers' in the form of drops, called Liprolac Baby. Liprolac Baby is the pioneer of probiotic supplement to support the role of breastmilk (ASI) and the growth of children specifically in the first 1000 days of life, therefore it is appropriate to be given in the early days of a child's life.

  • Maintaining Growth in Challenging Market Conditions

    Thursday, July 30, 2020
    Maintaining Growth in Challenging Market Conditions

    Jakarta, July 30, 2020 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced net sales of Rp 11,605 billion for the first semester of 2020, an increase of 3.8% compared to the same period last year of Rp 11,179 billion. 

  • Kalbe Does Disaster Care Action for Masamba

    Through Cleaning Public Facilities and Providing Medical Assistance

    Monday, July 27, 2020
    Kalbe Does Disaster Care Action for Masamba

    Masamba, 27 July 2020 - PT Kalbe Farma Tbk (Kalbe) today through the Kalbe Consumer Health Division which produces over-the-counter drugs (OTC) provides assistance to flood victims in North Luwu Regency, South Sulawesi, by conducting clean-up activities in public facilities, such as mosques, schools, and the neighborhood around the residents' homes. Furthermore, Kalbe also provides medicines as well as health education and conducts free medical examinations for disaster victims. 

RSS
12345Last